PubRank

Brian D Ross

Author PubWeight™ 173.26‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 2009 7.44
2 Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 2011 5.53
3 Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A 2005 4.63
4 Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A 2005 3.15
5 Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials 2007 3.12
6 Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med 2012 2.95
7 Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol 2010 2.90
8 Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 2008 2.84
9 It's not just about anatomy: in vivo bioluminescence imaging as an eyepiece into biology. J Magn Reson Imaging 2002 2.58
10 Towards hyperpolarized (13)C-succinate imaging of brain cancer. J Magn Reson 2007 2.57
11 Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin Cancer Res 2006 2.46
12 Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 2007 2.39
13 The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med 2009 2.32
14 The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia 2006 2.30
15 PASADENA hyperpolarization of succinic acid for MRI and NMR spectroscopy. J Am Chem Soc 2008 2.27
16 A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009 2.10
17 Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A 2002 1.93
18 Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging 2010 1.82
19 Survival prediction in high-grade gliomas by MRI perfusion before and during early stage of RT [corrected]. Int J Radiat Oncol Biol Phys 2005 1.79
20 Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons. J Neurosci 2003 1.72
21 Molecular imaging of Akt kinase activity. Nat Med 2007 1.68
22 Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 2006 1.66
23 A methodology for registration of a histological slide and in vivo MRI volume based on optimizing mutual information. Mol Imaging 2006 1.63
24 Multi-system repeatability and reproducibility of apparent diffusion coefficient measurement using an ice-water phantom. J Magn Reson Imaging 2012 1.57
25 PASADENA hyperpolarization of 13C biomolecules: equipment design and installation. MAGMA 2008 1.56
26 Hyperpolarized water as an MR imaging contrast agent: feasibility of in vivo imaging in a rat model. Radiology 2012 1.54
27 Clinical proton MR spectroscopy in central nervous system disorders. Radiology 2014 1.53
28 Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacy. Mol Imaging 2002 1.53
29 A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia 2007 1.50
30 Diffusion coefficient measurement using a temperature-controlled fluid for quality control in multicenter studies. J Magn Reson Imaging 2011 1.50
31 Magnetic resonance imaging determination of tumor grade and early response to temozolomide in a genetically engineered mouse model of glioma. Clin Cancer Res 2007 1.48
32 Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci U S A 2005 1.44
33 Therapeutic efficacy of DTI-015 using diffusion magnetic resonance imaging as an early surrogate marker. Clin Cancer Res 2004 1.42
34 Quality assurance of PASADENA hyperpolarization for 13C biomolecules. MAGMA 2008 1.41
35 Prospective analysis of parametric response map-derived MRI biomarkers: identification of early and distinct glioma response patterns not predicted by standard radiographic assessment. Clin Cancer Res 2011 1.39
36 Radiation-induced changes in normal-appearing white matter in patients with cerebral tumors: a diffusion tensor imaging study. Int J Radiat Oncol Biol Phys 2008 1.39
37 Diffusion imaging for therapy response assessment of brain tumor. Neuroimaging Clin N Am 2009 1.38
38 Real-time molecular imaging of tricarboxylic acid cycle metabolism in vivo by hyperpolarized 1-(13)C diethyl succinate. J Am Chem Soc 2011 1.36
39 Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res 2006 1.34
40 Prospective early response imaging biomarker for neoadjuvant breast cancer chemotherapy. Clin Cancer Res 2007 1.31
41 Parahydrogen-induced polarization (PHIP) hyperpolarized MR receptor imaging in vivo: a pilot study of 13C imaging of atheroma in mice. NMR Biomed 2011 1.27
42 Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study. MAGMA 2003 1.26
43 An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone. Cancer Res 2007 1.26
44 A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness. Neoplasia 2008 1.25
45 A novel polyacrylamide magnetic nanoparticle contrast agent for molecular imaging using MRI. Mol Imaging 2003 1.25
46 The use of 19F spectroscopy and diffusion-weighted MRI to evaluate differences in gene-dependent enzyme prodrug therapies. Mol Ther 2004 1.25
47 Dynamic imaging of emerging resistance during cancer therapy. Cancer Res 2006 1.23
48 Efficacy of proton magnetic resonance spectroscopy in neurological diagnosis and neurotherapeutic decision making. NeuroRx 2005 1.23
49 Noninvasive imaging of apoptosis and its application in cancer therapeutics. Clin Cancer Res 2008 1.21
50 Inhibition of furin/proprotein convertase-catalyzed surface and intracellular processing by small molecules. J Biol Chem 2009 1.20
51 Noninvasive molecular imaging sheds light on the synergy between 5-fluorouracil and TRAIL/Apo2L for cancer therapy. Clin Cancer Res 2007 1.16
52 The extent and severity of vascular leakage as evidence of tumor aggressiveness in high-grade gliomas. Cancer Res 2006 1.15
53 Diffusion imaging: insight to cell status and cytoarchitecture. Neuroimaging Clin N Am 2006 1.15
54 Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment. Inf Process Med Imaging 2009 1.15
55 Perifosine and CCI 779 co-operate to induce cell death and decrease proliferation in PTEN-intact and PTEN-deficient PDGF-driven murine glioblastoma. PLoS One 2011 1.12
56 Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy. Clin Cancer Res 2010 1.10
57 Molecular imaging of gene expression and efficacy following adenoviral-mediated brain tumor gene therapy. Mol Imaging 2003 1.10
58 Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol 2008 1.09
59 Cardiovascular applications of hyperpolarized contrast media and metabolic tracers. Exp Biol Med (Maywood) 2009 1.06
60 Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer. Mol Cancer Ther 2012 1.06
61 Sodium magnetic resonance imaging of chemotherapeutic response in a rat glioma. Magn Reson Med 2005 1.01
62 Nuclear localized phosphorylated FADD induces cell proliferation and is associated with aggressive lung cancer. Cell Cycle 2005 1.01
63 Intravoxel water diffusion heterogeneity imaging of human high-grade gliomas. NMR Biomed 2010 1.00
64 Fluorine-19 NMR chemical shift probes molecular binding to lipid membranes. J Phys Chem B 2008 1.00
65 Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors. Magn Reson Imaging 2006 0.99
66 Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas. J Magn Reson Imaging 2010 0.99
67 In vivo characterization of fatty acids in human adipose tissue using natural abundance 1H decoupled 13C MRS at 1.5 T: clinical applications to dietary therapy. NMR Biomed 2003 0.99
68 Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe. J Magn Reson 2008 0.99
69 Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clin Cancer Res 2005 0.99
70 Identification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity. Anal Biochem 2007 0.98
71 Continuous flow Overhauser dynamic nuclear polarization of water in the fringe field of a clinical magnetic resonance imaging system for authentic image contrast. J Magn Reson 2010 0.98
72 Analysis and correction of gradient nonlinearity bias in apparent diffusion coefficient measurements. Magn Reson Med 2014 0.98
73 Continuous arterial spin labeling using a train of adiabatic inversion pulses. J Magn Reson Imaging 2005 0.98
74 Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. NMR Biomed 2006 0.97
75 Glial dysfunction in abstinent methamphetamine abusers. J Cereb Blood Flow Metab 2009 0.97
76 DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. PLoS One 2012 0.96
77 Targeted imaging and therapy of brain cancer using theranostic nanoparticles. Mol Pharm 2010 0.94
78 Diffusion-weighted MRI for assessment of early cancer treatment response. Curr Pharm Biotechnol 2010 0.94
79 Quantitative determination of extracellular glutamine concentration in rat brain, and its elevation in vivo by system A transport inhibitor, alpha-(methylamino)isobutyrate. J Neurochem 2004 0.94
80 Molecular imaging of protein kinases. Cell Cycle 2007 0.93
81 Molecular imaging of glycogen synthase kinase-3beta and casein kinase-1alpha kinases. Anal Biochem 2010 0.92
82 Fast volumetric spatial-spectral MR imaging of hyperpolarized 13C-labeled compounds using multiple echo 3D bSSFP. Magn Reson Imaging 2010 0.92
83 Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. J Neurooncol 2010 0.91
84 Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers. Clin Cancer Res 2010 0.90
85 Glial uptake of neurotransmitter glutamate from the extracellular fluid studied in vivo by microdialysis and (13)C NMR. J Neurochem 2002 0.90
86 DCE and DW-MRI monitoring of vascular disruption following VEGF-Trap treatment of a rat glioma model. NMR Biomed 2011 0.90
87 Imaging proteolytic activity in live cells and animal models. PLoS One 2013 0.89
88 Kinetics of glial glutamine efflux and the mechanism of neuronal uptake studied in vivo in mildly hyperammonemic rat brain. J Neurochem 2006 0.89
89 Gd-enhanced cardiovascular MR imaging to identify left ventricular pseudoaneurysm. J Cardiovasc Magn Reson 2005 0.88
90 Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem 2009 0.88
91 Enhancing Akt imaging through targeted reporter expression. Mol Imaging 2009 0.88
92 Radiosynthesis and evaluation of 5-[125I]iodoindol-3-yl-beta-D-galactopyranoside as a beta-galactosidase imaging radioligand. Mol Imaging 2009 0.87
93 Inhibition of vascular endothelial growth factor (VEGF)-A causes a paradoxical increase in tumor blood flow and up-regulation of VEGF-D. Clin Cancer Res 2006 0.87
94 Intratumoral injection of BCNU in ethanol (DTI-015) results in enhanced delivery to tumor--a pharmacokinetic study. J Neurooncol 2005 0.87
95 Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults. Radiology 2009 0.87
96 Bioluminescence detection of cells having stabilized p53 in response to a genotoxic event. Mol Imaging 2004 0.87
97 Novel molecular imaging platform for monitoring oncological kinases. Cancer Cell Int 2010 0.87
98 Molecular imaging of c-Met tyrosine kinase activity. Anal Biochem 2011 0.87
99 MR spectroscopy in diagnosis and neurological decision-making. Semin Neurol 2008 0.87
100 Evaluation of D-methionine as a novel oral radiation protector for prevention of mucositis. Clin Cancer Res 2008 0.86
101 Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain. Brain Res 2010 0.86
102 Molecular imaging of epidermal growth factor receptor kinase activity. Anal Biochem 2011 0.86
103 Impact of evidence-based medicine on magnetic resonance spectroscopy. NMR Biomed 2006 0.86
104 Assessment of multiexponential diffusion features as MRI cancer therapy response metrics. Magn Reson Med 2010 0.85
105 Quantitative characterization of hemodynamic properties and vasculature dysfunction of high-grade gliomas. NMR Biomed 2007 0.85
106 Multimodality imaging of tumor and bone response in a mouse model of bony metastasis. Transl Oncol 2012 0.85
107 High-throughput molecular imaging for the identification of FADD kinase inhibitors. J Biomol Screen 2010 0.85
108 Synthesis and investigation of a radioiodinated F3 peptide analog as a SPECT tumor imaging radioligand. PLoS One 2011 0.84
109 Parametric response mapping of CT images provides early detection of local bone loss in a rat model of osteoporosis. Bone 2012 0.84
110 Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects. Subst Abuse 2010 0.84
111 Executive function changes before memory in preclinical Alzheimer's pathology: a prospective, cross-sectional, case control study. PLoS One 2013 0.84
112 DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases. Transl Oncol 2013 0.83
113 Multimodal imaging of growth and rapamycin-induced regression of colonic adenomas in apc mutation-dependent mouse. Transl Oncol 2012 0.83
114 Diffusion-Weighted MRI as a Biomarker of Tumor Radiation Treatment Response Heterogeneity: A Comparative Study of Whole-Volume Histogram Analysis versus Voxel-Based Functional Diffusion Map Analysis. Transl Oncol 2013 0.83
115 Suppression of glial glutamine release to the extracellular fluid studied in vivo by NMR and microdialysis in hyperammonemic rat brain. J Neurochem 2005 0.82
116 Molecular imaging reveals a role for AKT in resistance to cisplatin for ovarian endometrioid adenocarcinoma. Clin Cancer Res 2012 0.82
117 Guidelines for acquiring and reporting clinical neurospectroscopy. Semin Neurol 2013 0.81
118 Applications of molecular imaging. Prog Mol Biol Transl Sci 2010 0.81
119 Pharmacokinetic analysis and phase 1 study of MRX-1024 in patients treated with radiation therapy with or without cisplatinum for head and neck cancer. Clin Cancer Res 2010 0.81
120 In vivo microdialysis and gas-chromatography/mass-spectrometry for 13C-enrichment measurement of extracellular glutamate in rat brain. J Neurosci Methods 2002 0.81
121 PET and SPECT Imaging of Tumor Biology: New Approaches towards Oncology Drug Discovery and Development. Curr Comput Aided Drug Des 2008 0.81
122 A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB. Mol Cancer Ther 2011 0.80
123 Molecular imaging of akt enables early prediction of response to molecular targeted therapy. Transl Oncol 2011 0.80
124 Molecular imaging of the ATM kinase activity. Int J Radiat Oncol Biol Phys 2013 0.80
125 Imaging of proteolytic activity using a conditional cell surface receptor. Mol Imaging 2006 0.79
126 Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus. Epilepsy Res 2013 0.79
127 Cardiovascular magnetics resonance diagnosis of cystic tumor of the atrioventricular node. J Cardiovasc Magn Reson 2009 0.79
128 Evaluation of an automatic registration-based algorithm for direct measurement of volume change in tumors. Int J Radiat Oncol Biol Phys 2011 0.78
129 A review of the past, present, and future directions of neoplasia. Neoplasia 2005 0.77
130 Methylsulfonylmethane observed by in vivo proton magnetic resonance spectroscopy in a 5-year-old child with developmental disorder: effects of dietary supplementation. J Comput Assist Tomogr 2002 0.77
131 A transgenic mouse for imaging caspase-dependent apoptosis within the skin. J Invest Dermatol 2010 0.77
132 Innate properties of H-Wave device, a small fiber stimulator provides the basis for a paradigm shift of electro-therapeutic treatment of pain with increased functional restoration associated with human neuropathies by affecting tissue circulation: a hypothesis. Med Hypotheses 2005 0.76
133 Re: Long-term fetal cell transplant in Huntington disease: stayin' alive. Neurology 2008 0.75
134 Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Mol Imaging 2015 0.75
135 Impact of fasting on human brain acid-base homeostasis using natural abundance (13) C and (31) P MRS. J Magn Reson Imaging 2013 0.75
136 Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model. J R Stat Soc Ser C Appl Stat 2011 0.75
137 Magnetic resonance criteria for future trials of cardiac resynchronization therapy. J Cardiovasc Magn Reson 2005 0.75